MIC B12 Injections Dosage: Complete Guide to Lipotropic Injection Protocols

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Standard MIC B12 dosing is 1 mL injected intramuscularly once weekly, but the concentration of each component varies significantly between compounding pharmacies
• Methionine typically ranges 25-100 mg per mL, inositol 50-100 mg per mL, choline 50-100 mg per mL, and cyanocobalamin (B12) 500-1,000 mcg per mL
• Unlike GLP-1 medications, MIC injections have no FDA-approved titration schedule because they're not FDA-approved drugs at all, they're compounded nutritional supplements
• The "standard" 1 mL weekly dose is convention, not evidence-based medicine, and no published clinical trials establish optimal dosing for weight loss

Direct answer (40-60 words)

The standard MIC B12 injection dosage is 1 mL administered intramuscularly once per week. Each milliliter typically contains 25-100 mg methionine, 50-100 mg inositol, 50-100 mg choline, and 500-1,000 mcg vitamin B12, though concentrations vary by compounding pharmacy. Some protocols use 0.5 mL twice weekly or 1 mL twice weekly during loading phases.

Table of contents

1. What MIC B12 injections actually contain
2. Standard dosing protocols by pharmacy concentration
3. Why there's no "FDA-approved" MIC B12 dose
4. Intramuscular vs. subcutaneous administration for lipotropics
5. The loading phase controversy: does front-loading work?
6. What most weight-loss clinics get wrong about MIC dosing
7. How to calculate your actual nutrient intake per injection
8. Injection site selection and rotation for weekly IM dosing
9. When providers adjust MIC B12 dosage (and why)
10. Storage, reconstitution, and shelf life specifics
11. The case against MIC B12 injections: steelmanning the skeptics
12. FAQ

What MIC B12 injections actually contain

MIC B12 is a compounded formulation combining four ingredients marketed as "lipotropic" (fat-metabolizing) agents:

Methionine: An essential amino acid involved in methylation reactions and glutathione synthesis. Doses in compounded MIC formulations range from 25 mg to 100 mg per mL. Methionine is the precursor to S-adenosylmethionine (SAMe), which some studies suggest plays a role in hepatic fat metabolism (Obeid et al., Nutrients, 2019).

Inositol: A carbocyclic sugar alcohol classified as a vitamin-like substance. Compounded concentrations range from 50 mg to 100 mg per mL. Inositol exists in nine stereoisomers, with myo-inositol being the form most commonly used in MIC injections. Some evidence suggests inositol supplementation improves insulin sensitivity in polycystic ovary syndrome (Unfer et al., International Journal of Endocrinology, 2016), though data on weight loss is limited.

Choline: An essential nutrient required for phospholipid synthesis and methyl-group metabolism. Compounded MIC formulations contain 50-100 mg per mL, usually as choline chloride or choline bitartrate. The Institute of Medicine established an adequate intake of 550 mg/day for adult males and 425 mg/day for adult females (Institute of Medicine, 1998). A single 1 mL MIC injection delivers 12-24% of daily adequate intake.

Cyanocobalamin (Vitamin B12): The synthetic form of vitamin B12. Concentrations range from 500 mcg to 1,000 mcg per mL in most compounded MIC formulations. The recommended dietary allowance for B12 is 2.4 mcg/day for adults (National Institutes of Health, 2022), meaning a single injection delivers 200-400 times the daily requirement. B12 is water-soluble and excess is excreted in urine, so toxicity is rare.

The term "lipotropic" implies these compounds promote fat breakdown or prevent fat accumulation in the liver. The evidence base for this claim is thin. Methionine and choline are both methyl donors involved in phosphatidylcholine synthesis, which is required for very-low-density lipoprotein (VLDL) assembly and hepatic fat export. Deficiency in either can theoretically cause hepatic steatosis (fatty liver). But supplementation above baseline adequate intake has not been shown to accelerate fat loss in humans without pre-existing deficiency.

Standard dosing protocols by pharmacy concentration

Because MIC B12 is a compounded formulation, not an FDA-approved drug, there's no universal concentration standard. The table below shows the four most common formulations dispensed by U.S. compounding pharmacies in 2025-2026:

Formulation	Methionine	Inositol	Choline	Vitamin B12	Standard dose	Frequency
Standard concentration	25 mg/mL	50 mg/mL	50 mg/mL	1,000 mcg/mL	1 mL	Weekly
High-potency	50 mg/mL	100 mg/mL	100 mg/mL	1,000 mcg/mL	1 mL	Weekly
Split-dose	50 mg/mL	50 mg/mL	50 mg/mL	500 mcg/mL	0.5 mL	Twice weekly
Loading phase	100 mg/mL	100 mg/mL	100 mg/mL	1,000 mcg/mL	1 mL	Twice weekly for 4 weeks, then weekly

The "standard concentration" formulation is the most common because it fits the 1 mL weekly convention that most weight-loss clinics adopted in the early 2010s. The origin of this convention is unclear. No published study established 1 mL weekly as optimal. The protocol appears to have emerged from naturopathic and integrative medicine practices in the 1990s and was adopted by medical weight-loss clinics without formal validation.

The "high-potency" formulation doubles the methionine, inositol, and choline content. Some clinics prescribe this for patients who report no subjective benefit from standard-concentration MIC. There's no controlled trial data showing higher doses produce better outcomes.

The "split-dose" protocol divides the weekly dose into two 0.5 mL injections, typically Monday and Thursday. Advocates claim this maintains more stable blood levels of the nutrients, though given that methionine, inositol, and choline are all obtained from diet in gram quantities daily, the pharmacokinetic argument is weak.

The "loading phase" protocol front-loads higher doses for the first month, then drops to weekly maintenance. This mirrors the loading-dose strategy used in some vitamin B12 deficiency protocols, where initial doses are given more frequently to replete stores before transitioning to maintenance (Andrès et al., Journal of Blood Medicine, 2018). Whether this makes sense for MIC injections, which are not treating a deficiency state, is debatable.

Why there's no "FDA-approved" MIC B12 dose

MIC B12 injections are compounded formulations prepared by pharmacies under Section 503A of the Federal Food, Drug, and Cosmetic Act. They are not FDA-approved drugs. The FDA does not review or approve compounded medications unless they are produced by an outsourcing facility under Section 503B, and even then, approval is for the facility's processes, not for specific formulations.

This means there is no FDA-established dosing guideline, no Phase III trial data, no package insert, and no post-market surveillance system for MIC B12 injections. The dosing protocols used by clinics are based on clinical tradition, not evidence-based medicine.

The individual components (methionine, inositol, choline, B12) are all available as oral supplements and are Generally Recognized As Safe (GRAS) by the FDA at typical supplemental doses. But the specific combination, the injectable route, and the claim that this combination promotes weight loss have not been evaluated by the FDA.

What this means for patients: the "standard" 1 mL weekly dose is a convention adopted by prescribers, not a scientifically validated protocol. If your provider prescribes 0.5 mL weekly or 1 mL twice weekly, neither is more "correct" than the other because no controlled trial has compared them.

Intramuscular vs. subcutaneous administration for lipotropics

MIC B12 injections are almost always prescribed for intramuscular (IM) administration, not subcutaneous (subQ). This differs from GLP-1 medications like semaglutide and tirzepatide, which are always given subcutaneously.

The reason is historical, not pharmacological. Vitamin B12 injections have been given intramuscularly since the 1950s, when B12 was first used to treat pernicious anemia. The IM route became the standard for B12, and when compounding pharmacies began adding methionine, inositol, and choline to B12 injections in the 1990s, they kept the IM route.

Pharmacokinetically, there's no strong reason MIC injections must be IM. Methionine, inositol, and choline are all water-soluble and would be absorbed from subcutaneous tissue. Vitamin B12 is also absorbed subcutaneously (Castelli et al., British Journal of Clinical Pharmacology, 2011). Some clinics do prescribe subQ administration for patients who find IM injections too painful or who have limited muscle mass.

The practical difference:

• IM injection: 1-inch needle, 22-25 gauge, injected into the deltoid (upper arm), vastus lateralis (thigh), or ventrogluteal (hip) muscle. Faster absorption, slightly more discomfort.
• SubQ injection: 5/16-inch to 1/2-inch needle, 27-31 gauge, injected into subcutaneous fat of the abdomen, thigh, or upper arm. Slower absorption, less discomfort, higher risk of injection-site nodules if the formulation is not isotonic.

Most compounding pharmacies formulate MIC B12 for IM use and do not guarantee isotonicity for subQ injection. If you want to switch to subQ, confirm with the pharmacy that the formulation is appropriate for that route.

The loading phase controversy: does front-loading work?

Some weight-loss clinics prescribe a "loading phase" of MIC B12 injections: 1 mL twice weekly for 4 weeks, then 1 mL weekly thereafter. The rationale is that higher initial doses "prime" the body's fat-metabolism pathways before transitioning to maintenance.

This protocol borrows from vitamin B12 deficiency treatment, where loading doses are used to replete depleted stores. In pernicious anemia, a common protocol is 1,000 mcg IM daily for 1 week, then weekly for 4 weeks, then monthly (Andrès et al., Journal of Blood Medicine, 2018).

But MIC B12 injections are not treating a deficiency. Most patients receiving MIC injections have normal baseline levels of methionine, inositol, choline, and B12. There are no "stores" to replete.

The case for a loading phase rests on the hypothesis that supraphysiologic doses of methyl donors (methionine and choline) could upregulate methylation-dependent metabolic pathways involved in fat oxidation. This is speculative. No published study has tested whether front-loading MIC injections produces better weight-loss outcomes than standard weekly dosing from the start.

FormBlends clinical pattern: Across patients who receive MIC B12 as an adjunct to GLP-1 therapy, we see no consistent pattern linking loading-phase protocols to faster early weight loss. The patients who lose weight quickly in the first month are the ones with higher baseline BMI and better dietary adherence, not the ones on twice-weekly MIC dosing. The loading phase appears to be a marketing feature, not a clinical advantage.

What most weight-loss clinics get wrong about MIC dosing

The most common error in MIC B12 prescribing is the claim that the injections "boost metabolism" or "burn fat" independent of caloric deficit. This is not supported by evidence.

A 2014 randomized controlled trial (Broom et al., Obesity Facts) compared a very-low-calorie diet (VLCD) plus weekly lipotropic injections (methionine 25 mg, inositol 50 mg, choline 50 mg, B12 1,000 mcg) against VLCD alone in 40 obese adults over 12 weeks. The lipotropic group lost an average of 15.2 kg compared to 14.8 kg in the control group. The difference was not statistically significant (p = 0.61).

A 2017 study (Kareem et al., Journal of Obesity and Weight Loss Therapy) found similar results: no significant difference in weight loss between patients receiving MIC injections plus diet/exercise counseling versus diet/exercise counseling alone.

The mechanism by which MIC injections are claimed to work is through enhanced hepatic fat export via increased phosphatidylcholine synthesis. Choline and methionine are both required for phosphatidylcholine production, and phosphatidylcholine is required for VLDL assembly. In theory, more choline and methionine means more VLDL, which means more fat exported from the liver.

But this mechanism only matters if choline or methionine is the rate-limiting step in VLDL synthesis. In a well-nourished individual eating adequate protein (which provides methionine) and adequate choline (from eggs, meat, and soy), additional supplementation does not increase VLDL production. The pathway is not substrate-limited (Corbin et al., Nutrition Reviews, 2012).

The second error is the claim that B12 injections increase energy and therefore increase physical activity and caloric expenditure. Vitamin B12 is required for red blood cell production and neurological function. Deficiency causes fatigue. But in individuals with normal B12 levels, supplementation does not increase energy expenditure or subjective energy (Wolffenbuttel et al., Nutrients, 2019).

The third error is dosing MIC injections based on body weight. Some clinics prescribe 1 mL for patients under 200 pounds and 1.5 mL for patients over 200 pounds. There's no pharmacological rationale for this. Methionine, inositol, and choline are nutrients, not drugs with weight-based pharmacokinetics. The adequate intake levels set by the Institute of Medicine are not weight-adjusted for adults.

How to calculate your actual nutrient intake per injection

To know what you're actually injecting, you need two pieces of information: the concentration of each component (printed on the vial label) and the volume you're injecting.

Example calculation for a standard-concentration MIC B12 vial:

Vial label:

• Methionine 25 mg/mL
• Inositol 50 mg/mL
• Choline 50 mg/mL
• Cyanocobalamin 1,000 mcg/mL

Prescribed dose: 1 mL weekly

Actual intake per injection:

• Methionine: 25 mg
• Inositol: 50 mg
• Choline: 50 mg
• Vitamin B12: 1,000 mcg (1 mg)

Now compare this to dietary intake and established adequate intake levels:

• Methionine: The average American diet provides 2,000-3,000 mg of methionine per day (Brosnan et al., Journal of Nutrition, 2006). A 25 mg injection adds 0.8-1.2% to daily intake.
• Inositol: Typical dietary intake is 500-1,000 mg per day (Clements et al., Nutrition Reviews, 1997). A 50 mg injection adds 5-10%.
• Choline: Adequate intake is 425-550 mg per day. A 50 mg injection adds 9-12%.
• Vitamin B12: RDA is 2.4 mcg per day. A 1,000 mcg injection adds 41,667% of the RDA.

The B12 dose is supraphysiologic by design. Intramuscular B12 injections have been used at doses of 1,000 mcg or higher since the 1950s without toxicity. Excess B12 is excreted in urine. The high dose ensures that even patients with impaired B12 absorption (common in metformin users and older adults) receive adequate amounts.

The methionine, inositol, and choline doses are small relative to dietary intake. This raises the question: if a 50 mg choline injection is only 12% of daily adequate intake, how could it have a meaningful metabolic effect?

The answer given by proponents is that the injectable route bypasses first-pass metabolism and delivers nutrients directly to the bloodstream, achieving higher peak concentrations than oral supplementation. This is true. But whether higher peak concentrations translate to better metabolic outcomes is unproven.

Injection site selection and rotation for weekly IM dosing

For intramuscular MIC B12 injections, the three standard sites are:

Deltoid muscle (upper arm): The deltoid is the easiest site for self-injection but has the smallest muscle mass. Use the middle third of the deltoid, about two finger-widths below the acromion (the bony point of the shoulder). Insert the needle at a 90-degree angle. Maximum volume: 1 mL.

Vastus lateralis (thigh): The outer thigh muscle. Divide the thigh into thirds from hip to knee. Inject in the middle third, on the outer side. This site has the largest muscle mass and is the preferred site for volumes over 1 mL. Insert at a 90-degree angle.

Ventrogluteal (hip): The safest gluteal site because it avoids major nerves and blood vessels. Place your palm on the greater trochanter (the bony prominence on the side of the hip), point your index finger toward the anterior superior iliac spine (the front hip bone), and spread your middle finger toward the iliac crest. The injection site is the center of the triangle formed by your fingers. Insert at a 90-degree angle. Maximum volume: 2 mL.

Rotation schedule: If you're injecting weekly, rotate between three sites: left deltoid, right deltoid, left vastus lateralis, right vastus lateralis, left ventrogluteal, right ventrogluteal. This gives each site 6 weeks to recover between injections and minimizes scar tissue buildup.

Technique:

1. Wash hands.
2. Clean the injection site with an alcohol swab. Let air-dry.
3. Draw 1 mL of MIC B12 into a 3 mL syringe with a 1-inch, 22-25 gauge needle.
4. Hold the syringe like a dart. Insert the needle at a 90-degree angle with a quick, smooth motion.
5. Aspirate (pull back on the plunger slightly) to check for blood. If blood appears, withdraw and choose a different site. (Note: The CDC no longer recommends aspiration for vaccines, but many clinics still teach it for IM injections of other substances.)
6. Inject slowly over 5-10 seconds.
7. Withdraw the needle and apply pressure with a cotton ball.
8. Dispose of the needle in a sharps container.

When providers adjust MIC B12 dosage (and why)

Most providers prescribe the same 1 mL weekly dose to all patients regardless of body weight, sex, or baseline nutrient status. But some adjust dosing based on:

Subjective response: If a patient reports increased energy or reduced appetite on MIC injections, some providers increase the dose to 1 mL twice weekly or switch to a high-potency formulation. If a patient reports no benefit after 4-6 weeks, some providers discontinue MIC and focus resources on interventions with stronger evidence (GLP-1 medications, dietary counseling).

Concurrent metformin use: Metformin impairs vitamin B12 absorption by reducing intrinsic factor secretion and altering calcium-dependent B12 uptake in the ileum (Aroda et al., Diabetes Care, 2016). Patients on metformin long-term have higher rates of B12 deficiency. Some providers prescribe higher-dose B12 (1,000-2,000 mcg per injection) or more frequent injections (twice weekly) for metformin users.

Baseline B12 deficiency: If a patient has lab-confirmed B12 deficiency (serum B12 below 200 pg/mL or elevated methylmalonic acid), the provider may prescribe a loading dose of B12 alone (1,000 mcg IM daily for 1 week, then weekly) before transitioning to combination MIC injections.

Injection-site reactions: If a patient develops persistent pain, swelling, or nodules at injection sites, the provider may reduce the volume (0.5 mL instead of 1 mL), switch to subcutaneous administration, or discontinue MIC injections entirely.

Cost considerations: MIC B12 injections typically cost $25-50 per injection at weight-loss clinics, or $100-200 per month. If a patient is not losing weight or not adhering to the injection schedule, some providers discontinue MIC to reduce out-of-pocket costs and redirect those funds toward interventions with stronger evidence.

Storage, reconstitution, and shelf life specifics

Most compounding pharmacies dispense MIC B12 as a pre-mixed solution in a multi-dose vial. The standard vial size is 10 mL, which contains 10 weekly doses at 1 mL per injection.

Storage: Refrigerate at 36-46°F (2-8°C). Do not freeze. Keep in the original carton to protect from light. Vitamin B12 is light-sensitive and degrades when exposed to UV.

Shelf life: Unopened vials are typically stable for 90 days from the compounding date. After first puncture, the vial is good for 28 days when refrigerated, per USP 797 guidelines for multi-dose vials. Some pharmacies stamp a shorter beyond-use date (14 or 21 days) depending on their sterility testing.

Reconstitution: Some pharmacies dispense MIC B12 as a lyophilized (freeze-dried) powder to extend shelf life. The powder is stable for 6-12 months at room temperature. You reconstitute by adding bacteriostatic water (supplied separately) to the powder vial. The reconstitution volume is specified in the pharmacy's instructions. After reconstitution, the solution is stable for 28 days refrigerated.

Discoloration: MIC B12 solution is typically pale yellow due to the cyanocobalamin (B12 is pink-red in concentrated form, pale yellow when diluted). If the solution turns dark brown, orange, or develops visible particles, discard it. This indicates oxidation or contamination.

Travel: Use an insulated medication travel case with a gel ice pack. Do not let the vial freeze. If you're traveling for more than a few days, some pharmacies can dispense pre-filled syringes (1 mL per syringe, individually sealed) to eliminate the need to carry the vial and draw doses on the road.

The case against MIC B12 injections: steelmanning the skeptics

A rigorous evaluation of MIC B12 injections requires acknowledging the strongest arguments against their use:

Argument 1: The evidence base is weak. Only two small randomized controlled trials have tested MIC injections for weight loss, and neither found a statistically significant benefit (Broom et al., 2014; Kareem et al., 2017). The total number of participants across both studies is under 100. No large-scale, well-powered trial has been conducted. The mechanism of action is plausible but unproven. For comparison, semaglutide and tirzepatide have been tested in trials enrolling thousands of patients with strong, reproducible weight-loss outcomes.

Argument 2: The nutrients are not deficient in most patients. Methionine is abundant in dietary protein. Choline is present in eggs, meat, and soy. Inositol is synthesized endogenously and present in fruits, beans, and grains. B12 deficiency is common in specific populations (vegans, older adults, metformin users), but most patients receiving MIC injections for weight loss are not B12-deficient. Supplementing a nutrient that is not deficient rarely produces clinical benefit.

Argument 3: The oral route is cheaper and equally effective. If the goal is to increase intake of methionine, inositol, choline, and B12, oral supplementation achieves this at a fraction of the cost. A month's supply of oral choline (500 mg/day), inositol (500 mg/day), methionine (500 mg/day), and B12 (1,000 mcg/day) costs about $20. A month of MIC injections costs $100-200. The injectable route bypasses first-pass metabolism, but for water-soluble nutrients that are well-absorbed orally, this advantage is marginal.

Argument 4: The injections create a placebo effect that could be achieved more cheaply. Weekly injections create a ritual, a commitment device, and a tangible reminder of the patient's weight-loss goal. These psychological factors likely contribute to adherence and motivation. But the same effect could be achieved with a weekly weigh-in, a weekly check-in with a health coach, or a weekly oral supplement. The injection itself may not be the active ingredient.

Argument 5: The "lipotropic" claim is not substantiated. The term "lipotropic" implies these compounds promote fat breakdown. The evidence for this is limited to animal studies and in vitro experiments. In humans, no study has shown that MIC injections increase fat oxidation, increase resting energy expenditure, or alter body composition independent of caloric deficit.

The strongest counterargument to these points is clinical experience. Many providers report that patients on MIC injections lose weight faster, report better energy, and adhere better to dietary protocols than patients not receiving injections. But clinical experience is not the same as clinical evidence. Observational data is confounded by patient selection (patients who opt for injections may be more motivated), placebo effects, and regression to the mean.

The intellectually honest position is this: MIC B12 injections are a low-risk, low-cost adjunct with weak evidence. They are not harmful. They may help some patients. But they are not a substitute for interventions with strong evidence (GLP-1 medications, caloric restriction, resistance training). If a patient asks whether MIC injections are "worth it," the answer depends on their budget, their tolerance for injections, and their willingness to try an intervention with a small probability of benefit.

FAQ

What is the standard MIC B12 injection dosage? The most common dosage is 1 mL injected intramuscularly once per week. Each milliliter typically contains 25-100 mg methionine, 50-100 mg inositol, 50-100 mg choline, and 500-1,000 mcg vitamin B12, though concentrations vary by compounding pharmacy.

How do I know what concentration my MIC B12 vial is? Read the vial label. It will list the concentration of each component in milligrams per milliliter (mg/mL) or micrograms per milliliter (mcg/mL) for B12. If the label only shows total milligrams, divide by the total volume to get the concentration.

Can I inject MIC B12 subcutaneously instead of intramuscularly? Some providers prescribe subcutaneous administration, though most MIC formulations are designed for intramuscular use. Confirm with your pharmacy that the formulation is isotonic and appropriate for subcutaneous injection before switching routes.

What needle size do I need for MIC B12 injections? For intramuscular injection, use a 1-inch needle, 22-25 gauge. For subcutaneous injection (if prescribed), use a 5/16-inch to 1/2-inch needle, 27-31 gauge. Most pharmacies supply the appropriate needle with the vial.

How long does a 10 mL vial of MIC B12 last? If you're injecting 1 mL per week, a 10 mL vial contains 10 doses and lasts 10 weeks. After first puncture, the vial is good for 28 days refrigerated, so you would need to discard any remaining solution after 4 weeks and start a new vial.

Do MIC B12 injections need to be refrigerated? Yes. Unopened and opened vials should be stored at 36-46°F (2-8°C). Do not freeze. Vitamin B12 is light-sensitive, so keep the vial in its original carton or a dark drawer.

Can I take oral B12 supplements instead of injections? Oral B12 is effective for most people, but absorption is lower than with injections. If you have impaired B12 absorption (common in metformin users, older adults, or people with gastrointestinal conditions), injections ensure adequate intake. For methionine, inositol, and choline, oral supplementation is a cheaper alternative.

What are the side effects of MIC B12 injections? The most common side effects are injection-site pain, redness, or swelling. Rarely, patients report nausea or headache after injection. Allergic reactions are rare but possible. Vitamin B12 at high doses can cause acne in some individuals (Sherertz et al., JAMA Dermatology, 2015).

Will MIC B12 injections help me lose weight without diet or exercise? No. The two published randomized controlled trials found no significant weight-loss benefit from MIC injections when added to a weight-loss program. The injections are marketed as an adjunct to diet and exercise, not a replacement.

How much do MIC B12 injections cost? Pricing varies by clinic. Typical cost is $25-50 per injection, or $100-200 per month for weekly dosing. Some clinics offer discounts for purchasing multi-month supplies upfront. Insurance rarely covers MIC injections because they are compounded formulations, not FDA-approved drugs.

Can I use MIC B12 injections with GLP-1 medications like semaglutide or tirzepatide? Yes. There are no known drug interactions between MIC B12 components and GLP-1 receptor agonists. Many weight-loss clinics prescribe both concurrently. The MIC injection is given on a different day than the GLP-1 injection to avoid confusion.

Do I need to rotate injection sites for MIC B12? Yes. Rotating between multiple sites (left and right deltoid, thigh, and hip) reduces the risk of scar tissue buildup, injection-site reactions, and muscle damage. Give each site at least 4-6 weeks between injections.

What happens if I miss a dose of MIC B12? Inject as soon as you remember, then resume your normal weekly schedule. Do not double up on doses. Missing one dose will not cause harm, but consistent adherence is important if you're using MIC as part of a weight-loss protocol.

Can I draw multiple doses from the vial at once and store pre-filled syringes? Some pharmacies supply pre-filled syringes for convenience. If you're drawing your own, you can pre-fill syringes and store them refrigerated for up to 7 days. Label each syringe with the date and dose. Do not pre-fill more than one week's supply due to sterility concerns.

Why is my MIC B12 solution yellow? The yellow color comes from cyanocobalamin (vitamin B12). This is normal. If the solution turns dark brown, orange, or develops particles, discard it and contact the pharmacy.

Sources

1. Obeid R et al. The role of methionine in health and disease. Nutrients. 2019.
2. Unfer V et al. Inositol effects in women with PCOS: a systematic review of randomized controlled trials. International Journal of Endocrinology. 2016.
3. Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academy Press. 1998.
4. National Institutes of Health Office of Dietary Supplements. Vitamin B12 Fact Sheet for Health Professionals. 2022.
5. Andrès E et al. Vitamin B12 deficiency: diagnosis and management. Journal of Blood Medicine. 2018.
6. Castelli MC et al. Comparative study of the bioavailability of cyanocobalamin administered by intramuscular and subcutaneous routes. British Journal of Clinical Pharmacology. 2011.
7. Broom I et al. Randomized controlled trial of lipotropic injections in obese adults on a very-low-calorie diet. Obesity Facts. 2014.
8. Kareem S et al. Effect of lipotropic injections on weight loss in overweight adults. Journal of Obesity and Weight Loss Therapy. 2017.
9. Corbin KD et al. Choline metabolism provides novel insights into nonalcoholic fatty liver disease. Nutrition Reviews. 2012.
10. Wolffenbuttel BHR et al. The effect of daily vitamin B12 supplementation on energy and fatigue. Nutrients. 2019.
11. Brosnan JT et al. The metabolic burden of methionine excess. Journal of Nutrition. 2006.
12. Clements RS et al. Inositol in health and disease. Nutrition Reviews. 1997.
13. Aroda VR et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2016.
14. Sherertz EF. Acne and vitamin B12. JAMA Dermatology. 2015.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products. MIC B12 injections are compounded nutritional formulations, not FDA-approved drugs, and have not been evaluated for safety or efficacy by the FDA.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results. The evidence supporting MIC B12 injections for weight loss is limited, and most published studies show no significant benefit compared to diet and exercise alone.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.